Literature DB >> 13255892

Effect of insulinase-inhibitor on hypoglycemic action of insulin.

I A MIRSKY, G PERISUTTI.   

Abstract

Entities:  

Keywords:  HYPERINSULINISM/experimental; INSULIN/effects; PROTEASES

Mesh：

Substances：

Year:  1955        PMID： 13255892

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

Review 1.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

2.  Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.

Authors:  Malcolm A Leissring; Enrico Malito; Sabrine Hedouin; Lael Reinstatler; Tomoko Sahara; Samer O Abdul-Hay; Shakeel Choudhry; Ghulam M Maharvi; Abdul H Fauq; Malwina Huzarska; Philip S May; Sungwoon Choi; Todd P Logan; Benjamin E Turk; Lewis C Cantley; Marika Manolopoulou; Wei-Jen Tang; Ross L Stein; Gregory D Cuny; Dennis J Selkoe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

4.  Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.

Authors:  Samer O Abdul-Hay; Dongcheul Kang; Melinda McBride; Lilin Li; Ji Zhao; Malcolm A Leissring
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

5.  An in silico insight into novel therapeutic interaction of LTNF peptide-LT10 and design of structure based peptidomimetics for putative anti-diabetic activity.

Authors:  Sonali Gopichand Chavan; Deepti Dileep Deobagkar
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice.

Authors:  Rebecca Deprez-Poulain; Nathalie Hennuyer; Damien Bosc; Wenguang G Liang; Emmanuelle Enée; Xavier Marechal; Julie Charton; Jane Totobenazara; Gonzague Berte; Jouda Jahklal; Tristan Verdelet; Julie Dumont; Sandrine Dassonneville; Eloise Woitrain; Marion Gauriot; Charlotte Paquet; Isabelle Duplan; Paul Hermant; François-Xavier Cantrelle; Emmanuel Sevin; Maxime Culot; Valerie Landry; Adrien Herledan; Catherine Piveteau; Guy Lippens; Florence Leroux; Wei-Jen Tang; Peter van Endert; Bart Staels; Benoit Deprez
Journal:  Nat Commun       Date:  2015-09-23       Impact factor: 14.919

7.  Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display.

Authors:  Caitlin N Suire; Sarah Nainar; Michael Fazio; Adam G Kreutzer; Tara Paymozd-Yazdi; Caitlyn L Topper; Caroline R Thompson; Malcolm A Leissring
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

8.  The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE.

Authors:  Adrian Schmalen; Julia Karius-Fischer; Pia Rauch; Christian Setz; Klaus Korn; Petra Henklein; Torgils Fossen; Ulrich Schubert
Journal:  Viruses       Date:  2018-12-12       Impact factor: 5.048

Review 9.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

10.  Insulin-Degrading Enzyme: Paradoxes and Possibilities.

Authors:  Malcolm A Leissring
Journal:  Cells       Date:  2021-09-16       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.